These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33237772)

  • 21. Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention.
    Bertos NR; Gilquin B; Chan GK; Yen TJ; Khochbin S; Yang XJ
    J Biol Chem; 2004 Nov; 279(46):48246-54. PubMed ID: 15347674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
    Yu Q; Zhang H; Li Y; Liu C; Wang S; Liao X
    Mol Neurobiol; 2018 May; 55(5):3812-3821. PubMed ID: 28540657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
    Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two ZnF-UBP domains in isopeptidase T (USP5).
    Avvakumov GV; Walker JR; Xue S; Allali-Hassani A; Asinas A; Nair UB; Fang X; Zuo X; Wang YX; Wilkinson KD; Dhe-Paganon S
    Biochemistry; 2012 Feb; 51(6):1188-98. PubMed ID: 22283393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The double-edged sword effect of HDAC6 in Aβ toxicities.
    Cheng KC; Hwang YL; Chiang HC
    FASEB J; 2022 Jan; 36(1):e22072. PubMed ID: 34907598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity.
    Yan J; Seibenhener ML; Calderilla-Barbosa L; Diaz-Meco MT; Moscat J; Jiang J; Wooten MW; Wooten MC
    PLoS One; 2013; 8(9):e76016. PubMed ID: 24086678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.
    Osko JD; Christianson DW
    Biochemistry; 2019 Dec; 58(49):4912-4924. PubMed ID: 31755702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC6-p97/VCP controlled polyubiquitin chain turnover.
    Boyault C; Gilquin B; Zhang Y; Rybin V; Garman E; Meyer-Klaucke W; Matthias P; Müller CW; Khochbin S
    EMBO J; 2006 Jul; 25(14):3357-66. PubMed ID: 16810319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Dec; 77():318-330. PubMed ID: 30463049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
    Porter NJ; Mahendran A; Breslow R; Christianson DW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation.
    Ustinova K; Novakova Z; Saito M; Meleshin M; Mikesova J; Kutil Z; Baranova P; Havlinova B; Schutkowski M; Matthias P; Barinka C
    J Biol Chem; 2020 Feb; 295(9):2614-2628. PubMed ID: 31953325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.
    Yan J
    DNA Cell Biol; 2014 Sep; 33(9):567-80. PubMed ID: 24932665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
    Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
    BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini.
    Ouyang H; Ali YO; Ravichandran M; Dong A; Qiu W; MacKenzie F; Dhe-Paganon S; Arrowsmith CH; Zhai RG
    J Biol Chem; 2012 Jan; 287(4):2317-27. PubMed ID: 22069321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
    Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
    Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6.
    Harding RJ; Franzoni I; Mann MK; Szewczyk MM; Mirabi B; Ferreira de Freitas R; Owens DDG; Ackloo S; Scheremetjew A; Juarez-Ornelas KA; Sanichar R; Baker RJ; Dank C; Brown PJ; Barsyte-Lovejoy D; Santhakumar V; Schapira M; Lautens M; Arrowsmith CH
    J Med Chem; 2023 Aug; 66(15):10273-10288. PubMed ID: 37499118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
    Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.